Clinical Trial Update: A Double-Blind, Placebo-Controlled, Dose Ranging Study of Xanamem® in Healthy Elderly Volunteers [Phase 1, Phase 2]

View source ↗

Summary

Actinogen Medical completed a Phase 1/2 double-blind, placebo-controlled, dose-ranging trial of Xanamem in healthy elderly volunteers, with evaluation in mild c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Xanamem

Snippet

Sponsor: Actinogen Medical | Conditions: Mild Cognitive Impairment, Alzheimer's Disease | Phase 1, Phase 2 | Status: COMPLETED